Department of Dermatology, Fethi Sekin City Hospital, Elaziğ, Turkey.
Acta Dermatovenerol Alp Pannonica Adriat. 2023 Sep;32(3):83-86.
Anogenital warts (AGWs) are proliferative lesions mainly presenting in the anal, genital, and perianal regions. They are one of the most prevalent sexually transmitted infections globally.
The study included patients that presented at the Dermatology Clinic of Health Sciences, University Elaziğ, Fethi Sekin City Hospital between January 2019 and December 2022 and were diagnosed with AGWs. Patients that presented with this diagnosis and were screened for other sexually transmitted infections (HBsAg, anti-HBs, anti-HCV, anti-HIV, VDRL, and TPHA) were identified. Epidemiological and demographic patient data and the results of serological tests for other sexually transmitted infections in the last 4 years were analyzed. The patient data and examination results were collected retrospectively based on the hospital automated patient records.
AGW incidence was significantly higher in males. The mean patient age was 32, and the mean female patient age was lower than that of males. It was observed that the number of patients that were followed up with an AGW diagnosis increased significantly during the last 4 years (p < 0.05). The study detected 2.2% HBsAg, 0.6% TPHA, 0.3% VDRL, 0.5% anti-HCV, and 56.5% anti-HBs positivity. No anti-HIV-positive patients were identified. None of the patients had more than one sexually transmitted infection on serology testing.
Although the serological findings were higher when compared to certain studies and quite low when compared to others, it would be beneficial to evaluate all patients with AGWs for other sexually transmitted infections.
肛门生殖器疣(AGW)是一种主要出现在肛门、生殖器和肛周区域的增生性病变。它们是全球最普遍的性传播感染之一。
本研究纳入了 2019 年 1 月至 2022 年 12 月期间在埃尔祖鲁姆大学健康科学系皮肤科诊所就诊并被诊断为 AGW 的患者。对这些患者进行了其他性传播感染(HBsAg、抗-HBs、抗-HCV、抗-HIV、VDRL 和 TPHA)的筛查。分析了过去 4 年中患者的流行病学和人口统计学数据以及其他性传播感染的血清学检测结果。患者数据和检查结果是基于医院的自动患者记录进行回顾性收集的。
AGW 的发病率在男性中明显更高。患者的平均年龄为 32 岁,女性患者的平均年龄低于男性。研究观察到,过去 4 年中,因 AGW 诊断而接受随访的患者数量显著增加(p<0.05)。研究检测到 2.2%的 HBsAg、0.6%的 TPHA、0.3%的 VDRL、0.5%的抗-HCV 和 56.5%的抗-HBs 阳性。未发现抗-HIV 阳性患者。在血清学检测中,没有患者同时患有超过一种性传播感染。
尽管与某些研究相比,血清学检测结果较高,与其他研究相比则较低,但对所有 AGW 患者进行其他性传播感染的评估将是有益的。